<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04985630</url>
  </required_header>
  <id_info>
    <org_study_id>21.02.AMZ</org_study_id>
    <nct_id>NCT04985630</nct_id>
  </id_info>
  <brief_title>The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots</brief_title>
  <official_title>Open-labelled Study to Validate Home-based Use of a Health and Wellness Kit (The Mitopure Challenge) to Detect Levels of Urolithin A in Dried Blood Spots After Intake of Mitopure (Proprietary Urolithin A)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amazentis SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amazentis SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open labelled, virtual home based study to assess the test repeatability and the&#xD;
      failure/rejection rate of the samples collected at home by participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 30, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Failure/rejection rate (% of the samples) collected at home by participants.</measure>
    <time_frame>4 weeks</time_frame>
    <description>Acceptability target goal is to hit 80% of analyzed samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity (% of the samples) of the analytical method developed to test Urolithin A in dry blood spots.</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fold change increase in the levels of UA-Glucuronide (in ng/mL) in the dried blood spots provided in the kit before and after the challenge</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Validation of a health questionnaire on participants health status</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Healthy Aging</condition>
  <condition>Healthy</condition>
  <condition>Healthy Diet</condition>
  <arm_group>
    <arm_group_label>Mitopure Challenge to assess blood levels of Urolithin A after dietary and Mitopure intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mitopure challenge with diet (Pomegranate juice- Before) followed by Mitopure supplementation (After) to compare levels in blood spots of UA-Glucuronide (in ng/mL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mitopure</intervention_name>
    <description>Fruit flavored sachet containing fixed dose of Mitopureâ„¢ (Proprietary Urolithin A)</description>
    <arm_group_label>Mitopure Challenge to assess blood levels of Urolithin A after dietary and Mitopure intake</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pomegranate Juice</intervention_name>
    <description>100% Pomegranate juice</description>
    <arm_group_label>Mitopure Challenge to assess blood levels of Urolithin A after dietary and Mitopure intake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males and females 18 to 80 years of age;&#xD;
&#xD;
          2. Is in general good health, as determined by the research team;&#xD;
&#xD;
          3. Willingness to consume the investigation product, complete questionnaires and to&#xD;
             complete the study;&#xD;
&#xD;
          4. Have given voluntary, electronic, informed consent to be a participant in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Women who are pregnant, breastfeeding, or planning to become pregnant during the&#xD;
             course of the trial;&#xD;
&#xD;
          2. Volunteers who plan to donate blood during the study or within 30 days of completing&#xD;
             the study;&#xD;
&#xD;
          3. Subject has a known allergy to the test material's active or inactive ingredients;&#xD;
&#xD;
          4. Subjects with unstable medical conditions;&#xD;
&#xD;
          5. Participation in a clinical research trial within 30 days prior to randomization;&#xD;
&#xD;
          6. Allergy or sensitivity to study ingredients;&#xD;
&#xD;
          7. Individuals who are cognitively impaired and/or who are unable to give informed&#xD;
             consent;&#xD;
&#xD;
          8. Any other condition which in the Investigator's opinion may adversely affect the&#xD;
             subject's ability to complete the study or its measures or which may pose significant&#xD;
             risk to the subject;&#xD;
&#xD;
          9. Has taken antibiotics within the previous 30 days.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anurag Singh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amazentis SA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>William Blanco, PhD</last_name>
    <phone>+41215521277</phone>
    <email>wblanco@amazentis.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amazentis USA</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anurag Singh, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Singh A, D'Amico D, Andreux PA, Dunngalvin G, Kern T, Blanco-Bose W, Auwerx J, Aebischer P, Rinsch C. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population. Eur J Clin Nutr. 2021 Jun 11. doi: 10.1038/s41430-021-00950-1. [Epub ahead of print]</citation>
    <PMID>34117375</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 13, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2021</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

